|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CUL4B-SMG9 (FusionGDB2 ID:20688) |
Fusion Gene Summary for CUL4B-SMG9 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CUL4B-SMG9 | Fusion gene ID: 20688 | Hgene | Tgene | Gene symbol | CUL4B | SMG9 | Gene ID | 8450 | 56006 |
Gene name | cullin 4B | SMG9 nonsense mediated mRNA decay factor | |
Synonyms | CUL-4B|MRXHF2|MRXS15|MRXSC|SFM2 | C19orf61|F17127_1|HBMS | |
Cytomap | Xq24 | 19q13.31 | |
Type of gene | protein-coding | protein-coding | |
Description | cullin-4B | protein SMG9protein smg-9 homolog | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | Q13620 | . | |
Ensembl transtripts involved in fusion gene | ENST00000371322, ENST00000336592, ENST00000404115, ENST00000486604, | ENST00000270066, ENST00000601170, | |
Fusion gene scores | * DoF score | 5 X 6 X 4=120 | 7 X 4 X 7=196 |
# samples | 6 | 8 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/196*10)=-1.29278174922785 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CUL4B [Title/Abstract] AND SMG9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CUL4B(119680990)-SMG9(44244370), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CUL4B-SMG9 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. CUL4B-SMG9 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. CUL4B-SMG9 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. CUL4B-SMG9 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CUL4B | GO:0010498 | proteasomal protein catabolic process | 25970626 |
Hgene | CUL4B | GO:0035518 | histone H2A monoubiquitination | 22334663 |
Hgene | CUL4B | GO:0070914 | UV-damage excision repair | 22334663 |
Fusion gene breakpoints across CUL4B (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SMG9 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-D7-8574 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
Top |
Fusion Gene ORF analysis for CUL4B-SMG9 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000371322 | ENST00000270066 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
In-frame | ENST00000371322 | ENST00000601170 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
In-frame | ENST00000336592 | ENST00000270066 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
In-frame | ENST00000336592 | ENST00000601170 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
Frame-shift | ENST00000404115 | ENST00000270066 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
Frame-shift | ENST00000404115 | ENST00000601170 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
intron-3CDS | ENST00000486604 | ENST00000270066 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
intron-3CDS | ENST00000486604 | ENST00000601170 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000371322 | CUL4B | chrX | 119680990 | - | ENST00000270066 | SMG9 | chr19 | 44244370 | - | 2147 | 838 | 38 | 1699 | 553 |
ENST00000371322 | CUL4B | chrX | 119680990 | - | ENST00000601170 | SMG9 | chr19 | 44244370 | - | 2209 | 838 | 38 | 1624 | 528 |
ENST00000336592 | CUL4B | chrX | 119680990 | - | ENST00000270066 | SMG9 | chr19 | 44244370 | - | 2141 | 832 | 8 | 1693 | 561 |
ENST00000336592 | CUL4B | chrX | 119680990 | - | ENST00000601170 | SMG9 | chr19 | 44244370 | - | 2203 | 832 | 8 | 1618 | 536 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000371322 | ENST00000270066 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - | 0.006874532 | 0.99312544 |
ENST00000371322 | ENST00000601170 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - | 0.006041701 | 0.99395823 |
ENST00000336592 | ENST00000270066 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - | 0.008625438 | 0.99137455 |
ENST00000336592 | ENST00000601170 | CUL4B | chrX | 119680990 | - | SMG9 | chr19 | 44244370 | - | 0.010355406 | 0.98964465 |
Top |
Fusion Genomic Features for CUL4B-SMG9 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CUL4B-SMG9 |
Go to FGviewer for the breakpoints of chrX:119680990-chr19:44244370 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CUL4B | . |
FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit. CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation-induced DNA damage. Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication. Required for ubiquitination of cyclin E, and consequently, normal G1 cell cycle progression. Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism. Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8. With CUL4A, contributes to ribosome biogenesis (PubMed:26711351). {ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460, ECO:0000269|PubMed:26711351}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CUL4B | chrX:119680990 | chr19:44244370 | ENST00000371322 | - | 3 | 20 | 3_193 | 258.6666666666667 | 896.0 | Compositional bias | Note=Ser-rich |
Hgene | CUL4B | chrX:119680990 | chr19:44244370 | ENST00000404115 | - | 5 | 22 | 3_193 | 276.6666666666667 | 914.0 | Compositional bias | Note=Ser-rich |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SMG9 | chrX:119680990 | chr19:44244370 | ENST00000270066 | 5 | 14 | 71_133 | 233.66666666666666 | 521.0 | Compositional bias | Note=Pro-rich | |
Tgene | SMG9 | chrX:119680990 | chr19:44244370 | ENST00000601170 | 5 | 13 | 71_133 | 233.66666666666666 | 496.0 | Compositional bias | Note=Pro-rich |
Top |
Fusion Gene Sequence for CUL4B-SMG9 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000371322_ENST00000270066_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(transcript)=2147nt_BP=838nt CGCACGCAGGCATATAAACGTAGGTTTTTGATGCTCCTCTGCCTGTTGACCCCGCTATTTTCATGTTTCCAACAGGTTTTTCTTCCCCCA GTCCCTCAGCTGCTGCTGCTGCTCAGGAGGTCAGATCTGCCACTGATGGTAATACCAGCACCACTCCGCCCACCTCTGCCAAGAAGAGAA AGTTAAACAGCAGCAGCAGTAGCAGCAGTAACAGTAGTAACGAGAGAGAAGACTTTGATTCCACCTCTTCCTCCTCTTCCACTCCTCCTT TACAACCCAGGGATTCGGCATCCCCTTCAACCTCGTCCTTCTGCCTGGGGGTTTCAGTGGCTGCTTCCAGCCACGTACCGATACAGAAGA AGCTGCGTTTTGAAGACACCCTGGAGTTTGTAGGGTTTGATGCGAAGATGGCTGAGGAATCCTCCTCCTCCTCCTCCTCATCTTCACCAA CTGCTGCAACATCTCAGCAGCAGCAACTTAAAAATAAGAGTATATTAATCTCTTCTGTGGCTTCGGTGCATCATGCAAACGGCCTAGCCA AATCTTCTACCACCGTCTCTAGCTTTGCTAACAGCAAACCTGGCTCTGCTAAGAAGTTAGTGATCAAGAACTTTAAAGATAAGCCTAAAT TACCAGAAAACTACACAGATGAAACCTGGCAAAAACTGAAAGAAGCAGTGGAAGCTATTCAGAATAGTACTTCAATTAAGTACAATTTAG AAGAACTCTACCAGGCTGTAGAAAATCTCTGTTCTTACAAGATTTCTGCAAACTTGTACAAACAGCTGAGACAGATCTGCGAAGATCACA TCAAAGCACAGATTCATCAATTCAGAGAGACTTATGTTTTCCGGGCCCAGAGCGCTGAAATGAAGGAACGAGGGGGCAACCAGACCAGTG GCATCGACTTCTTTATTACCCAAGAACGGATTGTTTTCCTGGACACACAGCCCATCCTGAGCCCTTCTATCCTAGACCATCTCATCAATA ATGACCGCAAACTGCCTCCAGAGTACAACCTTCCCCACACTTACGTTGAAATGCAGTCACTCCAGATTGCTGCCTTCCTTTTCACGGTCT GCCATGTGGTGATTGTTGTCCAGGACTGGTTCACAGACCTCAGTCTCTACAGGTTCCTGCAGACAGCAGAGATGGTGAAGCCCTCCACCC CATCCCCCAGCCACGAGTCCAGCAGCTCATCGGGCTCCGATGAAGGCACCGAGTACTACCCCCACCTAGTCTTCTTGCAGAACAAAGCTC GCCGAGAGGACTTCTGTCCTCGGAAGCTGCGGCAGATGCACCTGATGATTGACCAGCTCATGGCCCACTCCCACCTGCGTTACAAGGGAA CTCTGTCCATGTTACAATGCAATGTCTTCCCGGGGCTTCCACCTGACTTCCTGGACTCTGAGGTCAACTTATTCCTGGTACCCTTCATGG ACAGTGAAGCAGAGAGTGAAAACCCACCAAGAGCAGGACCTGGTTCCAGCCCACTCTTCTCCCTGCTGCCTGGGTATCGTGGCCACCCCA GTTTCCAGTCCTTGGTGAGCAAGCTCCGGAGCCAAGTGATGTCCATGGCCCGGCCACAGCTGTCACACACGATCCTCACCGAGAAGAACT GGTTCCACTACGCTGCCCGGATCTGGGATGGGGTGAGAAAGTCCTCTGCTCTGGCAGAGTACAGCCGCCTGCTGGCCTGAGGCCAAGGAG AGGAATGTCATGCAGGGGACCTCCTGGGTCCGCAGTGTACTGCGAGGGAGCACAGATGTCCATCCCCCGCTGGGGTGGAGAGCGGCAGCA GGCCTGATGGATGAGGGATCGTGGCTTCCCGGCCCAGAGACATGAGGTGTCCAGGGCCAGGCCCCCCACCCTCAGTTGGGGCTGTTCCGG GGGTGACTGTGAGCGATCCCACCCCAAACCTGAGATGGGGTAGCCCGTCCTGTGTCCTCCACAGGGACAAGCAGTGGGAGGAGTCTGAAT GGTCACCAGGAAGCCCGGGCTCCATCTTGACCTCCTTTTTCAGGGACAGGAGCAACAGGCCCCTCTTCCCTGACTCTAAGCCCTTCCCTG >In-frame_ENST00000371322_ENST00000270066_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(amino acids)=553AA_start in transcript=38_stop in transcript=1699 MPVDPAIFMFPTGFSSPSPSAAAAAQEVRSATDGNTSTTPPTSAKKRKLNSSSSSSSNSSNEREDFDSTSSSSSTPPLQPRDSASPSTSS FCLGVSVAASSHVPIQKKLRFEDTLEFVGFDAKMAEESSSSSSSSSPTAATSQQQQLKNKSILISSVASVHHANGLAKSSTTVSSFANSK PGSAKKLVIKNFKDKPKLPENYTDETWQKLKEAVEAIQNSTSIKYNLEELYQAVENLCSYKISANLYKQLRQICEDHIKAQIHQFRETYV FRAQSAEMKERGGNQTSGIDFFITQERIVFLDTQPILSPSILDHLINNDRKLPPEYNLPHTYVEMQSLQIAAFLFTVCHVVIVVQDWFTD LSLYRFLQTAEMVKPSTPSPSHESSSSSGSDEGTEYYPHLVFLQNKARREDFCPRKLRQMHLMIDQLMAHSHLRYKGTLSMLQCNVFPGL PPDFLDSEVNLFLVPFMDSEAESENPPRAGPGSSPLFSLLPGYRGHPSFQSLVSKLRSQVMSMARPQLSHTILTEKNWFHYAARIWDGVR -------------------------------------------------------------- >In-frame_ENST00000371322_ENST00000601170_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(transcript)=2209nt_BP=838nt CGCACGCAGGCATATAAACGTAGGTTTTTGATGCTCCTCTGCCTGTTGACCCCGCTATTTTCATGTTTCCAACAGGTTTTTCTTCCCCCA GTCCCTCAGCTGCTGCTGCTGCTCAGGAGGTCAGATCTGCCACTGATGGTAATACCAGCACCACTCCGCCCACCTCTGCCAAGAAGAGAA AGTTAAACAGCAGCAGCAGTAGCAGCAGTAACAGTAGTAACGAGAGAGAAGACTTTGATTCCACCTCTTCCTCCTCTTCCACTCCTCCTT TACAACCCAGGGATTCGGCATCCCCTTCAACCTCGTCCTTCTGCCTGGGGGTTTCAGTGGCTGCTTCCAGCCACGTACCGATACAGAAGA AGCTGCGTTTTGAAGACACCCTGGAGTTTGTAGGGTTTGATGCGAAGATGGCTGAGGAATCCTCCTCCTCCTCCTCCTCATCTTCACCAA CTGCTGCAACATCTCAGCAGCAGCAACTTAAAAATAAGAGTATATTAATCTCTTCTGTGGCTTCGGTGCATCATGCAAACGGCCTAGCCA AATCTTCTACCACCGTCTCTAGCTTTGCTAACAGCAAACCTGGCTCTGCTAAGAAGTTAGTGATCAAGAACTTTAAAGATAAGCCTAAAT TACCAGAAAACTACACAGATGAAACCTGGCAAAAACTGAAAGAAGCAGTGGAAGCTATTCAGAATAGTACTTCAATTAAGTACAATTTAG AAGAACTCTACCAGGCTGTAGAAAATCTCTGTTCTTACAAGATTTCTGCAAACTTGTACAAACAGCTGAGACAGATCTGCGAAGATCACA TCAAAGCACAGATTCATCAATTCAGAGAGACTTATGTTTTCCGGGCCCAGAGCGCTGAAATGAAGGAACGAGGGGGCAACCAGACCAGTG GCATCGACTTCTTTATTACCCAAGAACGGATTGTTTTCCTGGACACACAGCCCATCCTGAGCCCTTCTATCCTAGACCATCTCATCAATA ATGACCGCAAACTGCCTCCAGAGTACAACCTTCCCCACACTTACGTTGAAATGCAGTCACTCCAGATTGCTGCCTTCCTTTTCACGGTCT GCCATGTGGTGATTGTTGTCCAGGACTGGTTCACAGACCTCAGTCTCTACAGGTTCCTGCAGACAGCAGAGATGGTGAAGCCCTCCACCC CATCCCCCAGCCACGAGTCCAGCAGCTCATCGGGCTCCGATGAAGGCACCGAGTACTACCCCCACCTAGTCTTCTTGCAGAACAAAGCTC GCCGAGAGGACTTCTGTCCTCGGAAGCTGCGGCAGATGCACCTGATGATTGACCAGCTCATGGCCCACTCCCACCTGCGTTACAAGGGAA CTCTGTCCATGTTACAATGCAATGTCTTCCCGGGGCTTCCACCTGACTTCCTGGACTCTGAGGTCAACTTATTCCTGGTACCCTTCATGG ACAGTGAAGCAGAGAGTGAAAACCCACCAAGAGCAGGACCTGGTTCCAGCCCACTCTTCTCCCTGCTGCCTGGGTATCGTGGCCACCCCA GTTTCCAGTCCTTGGTGAGCAAGCTCCGGAGCCAAGTGATGTCCATGGCCCGGCCACAGCTGTCACACACGATCCTCACCGAGAAGAACT GGTAAGAGCTCTTTGCAGAGGGGGTCAATTTGAGGCACCCCACCCTGGTGTAGAGAGAAGGGGGCGTCCCTTAGATCGGCATGACCTTGT GAAGCCCCTCCTCTCCAGATCCCAGGTTCCTTTTCTGGAACAGTGATGATTGCTACTGTCTTGTAAGCATCTCACCCATGTGGCAACATG CTGTTTCCTGTGACTTTGAATCCTCCTAATCAGCCAGCATCATGTAGGTCCTTGTCACCAGTTTTCCTGGTGGGGAAATTTAGGCTCGGG GAAAAGTGTTACATAGCAAGGCCACACATCTGTGGCTAGGAGTCATTTGATTGCTAGGAGTAGGACCAGTGACCAGATTTAGCTTAAGGA AGATTTATTCCAGGGACCTGATCACAGAAAGCAGGGCCCTGCAGCAGATGGGAACCAGGAAGCCATCAGGGTCTCATTCTTCACACTTCT GCATTTGTCTTGTTTCCTGCCTCTGGCTTTCTCTCCCTGCTTTCACTTGGCCCGGCACTAGCTCTGTGGCCCCTACTTTACATTACTTCT >In-frame_ENST00000371322_ENST00000601170_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(amino acids)=528AA_start in transcript=38_stop in transcript=1624 MPVDPAIFMFPTGFSSPSPSAAAAAQEVRSATDGNTSTTPPTSAKKRKLNSSSSSSSNSSNEREDFDSTSSSSSTPPLQPRDSASPSTSS FCLGVSVAASSHVPIQKKLRFEDTLEFVGFDAKMAEESSSSSSSSSPTAATSQQQQLKNKSILISSVASVHHANGLAKSSTTVSSFANSK PGSAKKLVIKNFKDKPKLPENYTDETWQKLKEAVEAIQNSTSIKYNLEELYQAVENLCSYKISANLYKQLRQICEDHIKAQIHQFRETYV FRAQSAEMKERGGNQTSGIDFFITQERIVFLDTQPILSPSILDHLINNDRKLPPEYNLPHTYVEMQSLQIAAFLFTVCHVVIVVQDWFTD LSLYRFLQTAEMVKPSTPSPSHESSSSSGSDEGTEYYPHLVFLQNKARREDFCPRKLRQMHLMIDQLMAHSHLRYKGTLSMLQCNVFPGL -------------------------------------------------------------- >In-frame_ENST00000336592_ENST00000270066_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(transcript)=2141nt_BP=832nt CTCAAGTCCTGCGGACCTGGGGGCTTCGGGATCTGGGCGCTATGAAAAGTGTCTGCCCAGTCACTTCCGGTTTTTCTTCCCCCAGTCCCT CAGCTGCTGCTGCTGCTCAGGAGGTCAGATCTGCCACTGATGGTAATACCAGCACCACTCCGCCCACCTCTGCCAAGAAGAGAAAGTTAA ACAGCAGCAGCAGTAGCAGCAGTAACAGTAGTAACGAGAGAGAAGACTTTGATTCCACCTCTTCCTCCTCTTCCACTCCTCCTTTACAAC CCAGGGATTCGGCATCCCCTTCAACCTCGTCCTTCTGCCTGGGGGTTTCAGTGGCTGCTTCCAGCCACGTACCGATACAGAAGAAGCTGC GTTTTGAAGACACCCTGGAGTTTGTAGGGTTTGATGCGAAGATGGCTGAGGAATCCTCCTCCTCCTCCTCCTCATCTTCACCAACTGCTG CAACATCTCAGCAGCAGCAACTTAAAAATAAGAGTATATTAATCTCTTCTGTGGCTTCGGTGCATCATGCAAACGGCCTAGCCAAATCTT CTACCACCGTCTCTAGCTTTGCTAACAGCAAACCTGGCTCTGCTAAGAAGTTAGTGATCAAGAACTTTAAAGATAAGCCTAAATTACCAG AAAACTACACAGATGAAACCTGGCAAAAACTGAAAGAAGCAGTGGAAGCTATTCAGAATAGTACTTCAATTAAGTACAATTTAGAAGAAC TCTACCAGGCTGTAGAAAATCTCTGTTCTTACAAGATTTCTGCAAACTTGTACAAACAGCTGAGACAGATCTGCGAAGATCACATCAAAG CACAGATTCATCAATTCAGAGAGACTTATGTTTTCCGGGCCCAGAGCGCTGAAATGAAGGAACGAGGGGGCAACCAGACCAGTGGCATCG ACTTCTTTATTACCCAAGAACGGATTGTTTTCCTGGACACACAGCCCATCCTGAGCCCTTCTATCCTAGACCATCTCATCAATAATGACC GCAAACTGCCTCCAGAGTACAACCTTCCCCACACTTACGTTGAAATGCAGTCACTCCAGATTGCTGCCTTCCTTTTCACGGTCTGCCATG TGGTGATTGTTGTCCAGGACTGGTTCACAGACCTCAGTCTCTACAGGTTCCTGCAGACAGCAGAGATGGTGAAGCCCTCCACCCCATCCC CCAGCCACGAGTCCAGCAGCTCATCGGGCTCCGATGAAGGCACCGAGTACTACCCCCACCTAGTCTTCTTGCAGAACAAAGCTCGCCGAG AGGACTTCTGTCCTCGGAAGCTGCGGCAGATGCACCTGATGATTGACCAGCTCATGGCCCACTCCCACCTGCGTTACAAGGGAACTCTGT CCATGTTACAATGCAATGTCTTCCCGGGGCTTCCACCTGACTTCCTGGACTCTGAGGTCAACTTATTCCTGGTACCCTTCATGGACAGTG AAGCAGAGAGTGAAAACCCACCAAGAGCAGGACCTGGTTCCAGCCCACTCTTCTCCCTGCTGCCTGGGTATCGTGGCCACCCCAGTTTCC AGTCCTTGGTGAGCAAGCTCCGGAGCCAAGTGATGTCCATGGCCCGGCCACAGCTGTCACACACGATCCTCACCGAGAAGAACTGGTTCC ACTACGCTGCCCGGATCTGGGATGGGGTGAGAAAGTCCTCTGCTCTGGCAGAGTACAGCCGCCTGCTGGCCTGAGGCCAAGGAGAGGAAT GTCATGCAGGGGACCTCCTGGGTCCGCAGTGTACTGCGAGGGAGCACAGATGTCCATCCCCCGCTGGGGTGGAGAGCGGCAGCAGGCCTG ATGGATGAGGGATCGTGGCTTCCCGGCCCAGAGACATGAGGTGTCCAGGGCCAGGCCCCCCACCCTCAGTTGGGGCTGTTCCGGGGGTGA CTGTGAGCGATCCCACCCCAAACCTGAGATGGGGTAGCCCGTCCTGTGTCCTCCACAGGGACAAGCAGTGGGAGGAGTCTGAATGGTCAC CAGGAAGCCCGGGCTCCATCTTGACCTCCTTTTTCAGGGACAGGAGCAACAGGCCCCTCTTCCCTGACTCTAAGCCCTTCCCTGTAAGGT >In-frame_ENST00000336592_ENST00000270066_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(amino acids)=561AA_start in transcript=8_stop in transcript=1693 MRTWGLRDLGAMKSVCPVTSGFSSPSPSAAAAAQEVRSATDGNTSTTPPTSAKKRKLNSSSSSSSNSSNEREDFDSTSSSSSTPPLQPRD SASPSTSSFCLGVSVAASSHVPIQKKLRFEDTLEFVGFDAKMAEESSSSSSSSSPTAATSQQQQLKNKSILISSVASVHHANGLAKSSTT VSSFANSKPGSAKKLVIKNFKDKPKLPENYTDETWQKLKEAVEAIQNSTSIKYNLEELYQAVENLCSYKISANLYKQLRQICEDHIKAQI HQFRETYVFRAQSAEMKERGGNQTSGIDFFITQERIVFLDTQPILSPSILDHLINNDRKLPPEYNLPHTYVEMQSLQIAAFLFTVCHVVI VVQDWFTDLSLYRFLQTAEMVKPSTPSPSHESSSSSGSDEGTEYYPHLVFLQNKARREDFCPRKLRQMHLMIDQLMAHSHLRYKGTLSML QCNVFPGLPPDFLDSEVNLFLVPFMDSEAESENPPRAGPGSSPLFSLLPGYRGHPSFQSLVSKLRSQVMSMARPQLSHTILTEKNWFHYA -------------------------------------------------------------- >In-frame_ENST00000336592_ENST00000601170_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(transcript)=2203nt_BP=832nt CTCAAGTCCTGCGGACCTGGGGGCTTCGGGATCTGGGCGCTATGAAAAGTGTCTGCCCAGTCACTTCCGGTTTTTCTTCCCCCAGTCCCT CAGCTGCTGCTGCTGCTCAGGAGGTCAGATCTGCCACTGATGGTAATACCAGCACCACTCCGCCCACCTCTGCCAAGAAGAGAAAGTTAA ACAGCAGCAGCAGTAGCAGCAGTAACAGTAGTAACGAGAGAGAAGACTTTGATTCCACCTCTTCCTCCTCTTCCACTCCTCCTTTACAAC CCAGGGATTCGGCATCCCCTTCAACCTCGTCCTTCTGCCTGGGGGTTTCAGTGGCTGCTTCCAGCCACGTACCGATACAGAAGAAGCTGC GTTTTGAAGACACCCTGGAGTTTGTAGGGTTTGATGCGAAGATGGCTGAGGAATCCTCCTCCTCCTCCTCCTCATCTTCACCAACTGCTG CAACATCTCAGCAGCAGCAACTTAAAAATAAGAGTATATTAATCTCTTCTGTGGCTTCGGTGCATCATGCAAACGGCCTAGCCAAATCTT CTACCACCGTCTCTAGCTTTGCTAACAGCAAACCTGGCTCTGCTAAGAAGTTAGTGATCAAGAACTTTAAAGATAAGCCTAAATTACCAG AAAACTACACAGATGAAACCTGGCAAAAACTGAAAGAAGCAGTGGAAGCTATTCAGAATAGTACTTCAATTAAGTACAATTTAGAAGAAC TCTACCAGGCTGTAGAAAATCTCTGTTCTTACAAGATTTCTGCAAACTTGTACAAACAGCTGAGACAGATCTGCGAAGATCACATCAAAG CACAGATTCATCAATTCAGAGAGACTTATGTTTTCCGGGCCCAGAGCGCTGAAATGAAGGAACGAGGGGGCAACCAGACCAGTGGCATCG ACTTCTTTATTACCCAAGAACGGATTGTTTTCCTGGACACACAGCCCATCCTGAGCCCTTCTATCCTAGACCATCTCATCAATAATGACC GCAAACTGCCTCCAGAGTACAACCTTCCCCACACTTACGTTGAAATGCAGTCACTCCAGATTGCTGCCTTCCTTTTCACGGTCTGCCATG TGGTGATTGTTGTCCAGGACTGGTTCACAGACCTCAGTCTCTACAGGTTCCTGCAGACAGCAGAGATGGTGAAGCCCTCCACCCCATCCC CCAGCCACGAGTCCAGCAGCTCATCGGGCTCCGATGAAGGCACCGAGTACTACCCCCACCTAGTCTTCTTGCAGAACAAAGCTCGCCGAG AGGACTTCTGTCCTCGGAAGCTGCGGCAGATGCACCTGATGATTGACCAGCTCATGGCCCACTCCCACCTGCGTTACAAGGGAACTCTGT CCATGTTACAATGCAATGTCTTCCCGGGGCTTCCACCTGACTTCCTGGACTCTGAGGTCAACTTATTCCTGGTACCCTTCATGGACAGTG AAGCAGAGAGTGAAAACCCACCAAGAGCAGGACCTGGTTCCAGCCCACTCTTCTCCCTGCTGCCTGGGTATCGTGGCCACCCCAGTTTCC AGTCCTTGGTGAGCAAGCTCCGGAGCCAAGTGATGTCCATGGCCCGGCCACAGCTGTCACACACGATCCTCACCGAGAAGAACTGGTAAG AGCTCTTTGCAGAGGGGGTCAATTTGAGGCACCCCACCCTGGTGTAGAGAGAAGGGGGCGTCCCTTAGATCGGCATGACCTTGTGAAGCC CCTCCTCTCCAGATCCCAGGTTCCTTTTCTGGAACAGTGATGATTGCTACTGTCTTGTAAGCATCTCACCCATGTGGCAACATGCTGTTT CCTGTGACTTTGAATCCTCCTAATCAGCCAGCATCATGTAGGTCCTTGTCACCAGTTTTCCTGGTGGGGAAATTTAGGCTCGGGGAAAAG TGTTACATAGCAAGGCCACACATCTGTGGCTAGGAGTCATTTGATTGCTAGGAGTAGGACCAGTGACCAGATTTAGCTTAAGGAAGATTT ATTCCAGGGACCTGATCACAGAAAGCAGGGCCCTGCAGCAGATGGGAACCAGGAAGCCATCAGGGTCTCATTCTTCACACTTCTGCATTT GTCTTGTTTCCTGCCTCTGGCTTTCTCTCCCTGCTTTCACTTGGCCCGGCACTAGCTCTGTGGCCCCTACTTTACATTACTTCTTTGTCC >In-frame_ENST00000336592_ENST00000601170_TCGA-D7-8574_CUL4B_chrX_119680990_-_SMG9_chr19_44244370_length(amino acids)=536AA_start in transcript=8_stop in transcript=1618 MRTWGLRDLGAMKSVCPVTSGFSSPSPSAAAAAQEVRSATDGNTSTTPPTSAKKRKLNSSSSSSSNSSNEREDFDSTSSSSSTPPLQPRD SASPSTSSFCLGVSVAASSHVPIQKKLRFEDTLEFVGFDAKMAEESSSSSSSSSPTAATSQQQQLKNKSILISSVASVHHANGLAKSSTT VSSFANSKPGSAKKLVIKNFKDKPKLPENYTDETWQKLKEAVEAIQNSTSIKYNLEELYQAVENLCSYKISANLYKQLRQICEDHIKAQI HQFRETYVFRAQSAEMKERGGNQTSGIDFFITQERIVFLDTQPILSPSILDHLINNDRKLPPEYNLPHTYVEMQSLQIAAFLFTVCHVVI VVQDWFTDLSLYRFLQTAEMVKPSTPSPSHESSSSSGSDEGTEYYPHLVFLQNKARREDFCPRKLRQMHLMIDQLMAHSHLRYKGTLSML -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CUL4B-SMG9 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CUL4B-SMG9 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CUL4B-SMG9 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CUL4B | C1845861 | MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT | 9 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | CUL4B | C1845845 | MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE (disorder) | 3 | CLINGEN |
Hgene | CUL4B | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
Tgene | SMG9 | C4310793 | HEART AND BRAIN MALFORMATION SYNDROME | 2 | CTD_human;GENOMICS_ENGLAND |